Validation of the Novel Web-Based Application HUMTELEMED for a Comprehensive Assessment of Cardiovascular Risk Based on the 2021 European Society of Cardiology Guidelines.

导出 LinkOut

翻译打印收藏纠错

作者： Matteo,Landolfo ^[1] ; Francesco,Spannella ^[2] ; Alessandro,Gezzi ^[1] ; Federico,Giulietti ^[2] ; Lucia,Sabbatini ^[1] ; Isabella,Bari ^[2] ; Romina,Alessandroni ^[1] ; Angelica,Di Agostini ^[1] ; Paolo,Turri ^[2] ; Francesco,Alborino ^[1] ; Lorenzo,Scoppolini Massini ^[2] ; Riccardo,Sarzani ^[1]

作者单位： Internal Medicine and Geriatrics, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale di Ricovero e Cura per gli Anziani (INRCA), 60127 Ancona, Italy. ^[1] Department of Clinical and Molecular Sciences (DISCLIMO), Centre of Obesity, University "Politecnica delle Marche", 60127 Ancona, Italy. ^[2] AIDAPT Srl, 60127 Ancona, Italy. ^[3]

关键词 SCORE2 SCORE2-OP cardiovascular risk dyslipidemia humtelemed hypertension

DOI 10.3390/jcm13082295

PMID 38673568

发布时间 2024-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2024年13卷8期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Validation of the Novel Web-Based Application HUMTELEMED for a Comprehensive Assessment of Cardiovascular Risk Based on the 2021 European Society of Cardiology Guidelines.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Validation of the Novel Web-Based Application HUMTELEMED for a Comprehensive Assessment of Cardiovascular Risk Based on the 2021 European Society of Cardiology Guidelines.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除